Alemtuzumab in the Treatment of Chronic Lymphocytic Leukemia
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in BioDrugs
- Vol. 19 (1) , 9-22
- https://doi.org/10.2165/00063030-200519010-00002
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Monoclonal Antibodies in the Treatment of Chronic Lymphoid LeukemiasLeukemia & Lymphoma, 2004
- Rituximab in B-Cell chronic lymphocytic leukemiaSeminars in Oncology, 2003
- Alemtuzumab therapy in B-cell lymphoproliferative disordersSeminars in Oncology, 2003
- Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemiaLeukemia, 2002
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemiaCancer, 1997
- Key issues in the treatment of chronic lymphocytic leukaemia (CLL)European Journal Of Cancer, 1995
- Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1995
- Advances in the biology and treatment of B-cell chronic lymphocytic leukemiaBlood, 1995
- Clinical staging of chronic lymphocytic leukemiaBlood, 1975